As part of its commitment towards communities around the world, Capgemini has joined UNICEF’s efforts to help ensure equitable access to COVID-19 vaccines, tests and treatments around the world.
The Capgemini Group, through its Social Response Unit, has committed two million euros to support UNICEF’s work as part of the global Access to COVID19 Tools Accelerator (ACT-A), with a focus on India and Brazil in particular.
ACT-A is a global collaboration that aims to accelerate the development, production and equitable access to COVID-19 tests, treatments and vaccines. On behalf of the Global COVAX Facility (the vaccine strand of ACT-A) UNICEF is leading the largest vaccine procurement and supply operation ever undertaken, aiming to make 2 billion doses of the COVID-19 vaccine available for delivery by the end of 2021.
“As a global leader with a strong sense of responsibility to the communities in which we live and work, we have strengthened our efforts in recent weeks to face the urgency of local situations head on,” said Aiman Ezzat, CEO of the Capgemini Group. “At this critical time where many places such as Brazil and India are continuing to live with the harsh reality of COVID-19, we are committed to accelerate medical assistance and equitable access to the vaccine. We encourage private companies to join UNICEF’s efforts with us in this unprecedented global fight.”
”We are extremely grateful for Capgemini’s support to UNICEF in its efforts to fight COVID-19. The commitment of the Group and its employees will allow UNICEF to help the most vulnerable, especially in India and Brazil where COVID-19 is having significant consequences,” explains Jean-Marie Dru, Chairman of UNICEF France. “Through ACT-A and in its role to support the COVAX Facility, UNICEF and partners are in a race to end this pandemic which has been disrupting the lives of children and their families for over a year now. This is why, now more than ever, we need the help and support of our donors and partners to join the race to end COVID-19.”
Capgemini supports UNICEF’s efforts to end the COVID-19 global pandemic
As well as helping to provide safe, fast and equitable access to COVID-19 vaccines, tests and treatments, UNICEF is supporting risk communication, community engagement and country preparedness efforts for the vaccine roll out, while supporting the strengthening of health systems.
This latest commitment by Capgemini will include specific support for the most urgent and critical needs in India and Brazil, in addition to supporting the ACT-A alliance through UNICEF.
